Vamorolone Production Cost Reports

The report provides a detailed analysis essential for establishing a Vamorolone production plant. It encompasses all critical aspects necessary for Vamorolone production, including the cost of Vamorolone production, Vamorolone plant cost, Vamorolone production costs, and the overall Vamorolone production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Vamorolone production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Vamorolone is a synthetic medicine similar to steroids but designed to work better with fewer side effects. It helps reduce inflammation and calm the immune system without causing bone problems or stunted growth like some steroids. Its special chemical structure makes it stronger and helps protect the heart by stopping excess fluid retention and fibrosis.

It is used in the treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and older. It improves motor function, stabilises disease progression, and provides a safer alternative to prednisone. It is an FDA-approved drug and is available in oral suspension. Its common side effects include puffy face, fat deposits, weight gain, vomiting, and vitamin D deficiency.

The market for Vamorolone is driven by its usage as a corticosteroid alternative to treat Duchenne muscular dystrophy. Its advantage over traditional glucocorticoids, by preserving motor function more effectively, makes it a popular drug. It reduces common side effects like growth impairment, bone loss, and other metabolic issues associated with long-term steroid use, which fuels its market.

Its approval is also fuelled by orphan drug incentives, which encourage development and commercialisation for rare diseases, as well as increased awareness and diagnosis of DMD globally. The industrial Vamorolone procurement is affected by its status as a patented orphan drug with high pricing, but patient assistance programs help ease costs. Also, the lack of generic competition because of recent market entry, along with regulatory complexities in emerging markets, affects its sourcing strategies.

Raw Material for Vamorolone Production

According to the Vamorolone production plant project report, the key raw materials used in the production of Vamorolone include 8-DM or 3-TR (Steroid Precursors)-Acetic Anhydride- 4-(Dimethylamino)pyridine (DMP)-Tetrahydrofuran (THF)-Hydrogen Iodide.

Production Process of Vamorolone

The extensive Vamorolone production cost report consists of the following major industrial production process:

1. From Steroid Precursors: The production process of Vamorolone involves steroid precursors like 8-DM or 3-TR. First, acetylation modifies the precursor using acetic anhydride and catalytic DMAP in THF, followed by quenching and isolation of 8-DM Acetate. After that, deoxygenation treats the acetate with aqueous hydrogen iodide in toluene/AcOH at low temperature to form Vamorolone Acetate. Finally, deacetylation is done using potassium carbonate in MeOH/water, and the crude product is purified to get Vamorolone as the final product.

Vamorolone is a slightly hygroscopic, micronised white to light yellow solid powder. It has a molecular formula of C22H28O4 and a molecular weight of 356.46 g/mol. It shows poor aqueous solubility across physiological pH ranges but high solubility in DMSO. It is stable when stored as a powder at -20 degree Celsius. It has a logP value of 2.49, which makes it moderately lipophilic. It has a topological polar surface area of 74.6 Ų with 2 hydrogen bond donors, 4 hydrogen bond acceptors, 2 rotatable bonds, and 6 chiral centres. It has a double bond in the steroid structure that improves its stability against inactivating enzymes, which supports its oral suspension formulations.